Approvals/TGA/CIPLA BECLOMETASONE/FORMOTEROL 200/6 beclometasone dipropionate 200 mcg formoterol fumarate dihydrate 6 mcg pressurised inhalation aerosol can

Approved

STANDARD

CIPLA BECLOMETASONE/FORMOTEROL 200/6 beclometasone dipropionate 200 mcg formoterol fumarate dihydrate 6 mcg pressurised inhalation aerosol can

Cipla Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Date: May 30, 2025
Approval ID: 3f86d5e4013c7657
Company: Cipla Australia Pty Ltd
Type: Standard

Approval Details

Approval Id: 3f86d5e4013c7657
Product Name: CIPLA BECLOMETASONE/FORMOTEROL 200/6 beclometasone dipropionate 200 mcg formoterol fumarate dihydrate 6 mcg pressurised inhalation aerosol can
Artg Id: 408416
Artg Name: CIPLA BECLOMETASONE/FORMOTEROL 200/6 beclometasone dipropionate 200 mcg formoterol fumarate dihydrate 6 mcg pressurised inhalation aerosol can
Sponsor: Cipla Australia Pty Ltd
Company Detail Path: /organization/cipla-australia-pty-ltd
Artg Date: 2025-03-24
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Active Ingredients

Approved

Quick Info

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

3f86d5e4013c7657

Type

Standard

Back to TGA Approvals